Lexeo Therapeutics Statistics

Total Valuation

LXEO has a market cap or net worth of $682.43 million. The enterprise value is $568.12 million.

Market Cap	682.43M
Enterprise Value	568.12M

Important Dates

The last earnings date was Wednesday, November 5, 2025, before market open.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

LXEO has 72.99 million shares outstanding. The number of shares has increased by 54.63% in one year.

Current Share Class	72.99M
Shares Outstanding	72.99M
Shares Change (YoY)	+54.63%
Shares Change (QoQ)	+39.95%
Owned by Insiders (%)	0.29%
Owned by Institutions (%)	53.95%
Float	48.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.25
P/TBV Ratio	5.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.40, with a Debt / Equity ratio of 0.07.

Current Ratio	7.40
Quick Ratio	7.11
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,081.17

Financial Efficiency

Return on equity (ROE) is -80.69% and return on invested capital (ROIC) is -50.86%.

Return on Equity (ROE)	-80.69%
Return on Assets (ROA)	-44.66%
Return on Invested Capital (ROIC)	-50.86%
Return on Capital Employed (ROCE)	-89.69%
Revenue Per Employee	n/a
Profits Per Employee	-$1.46M
Employee Count	72
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.52% in the last 52 weeks. The beta is 1.78, so LXEO's price volatility has been higher than the market average.

Beta (5Y)	1.78
52-Week Price Change	+38.52%
50-Day Moving Average	8.70
200-Day Moving Average	5.07
Relative Strength Index (RSI)	53.81
Average Volume (20 Days)	1,154,097

Short Selling Information

The latest short interest is 5.64 million, so 7.72% of the outstanding shares have been sold short.

Short Interest	5.64M
Short Previous Month	5.18M
Short % of Shares Out	7.72%
Short % of Float	11.70%
Short Ratio (days to cover)	3.95

Income Statement

Revenue	n/a
Gross Profit	-65.95M
Operating Income	-113.52M
Pretax Income	-104.97M
Net Income	-104.97M
EBITDA	-112.93M
EBIT	-113.52M
Earnings Per Share (EPS)	-$2.45

Full Income Statement

Balance Sheet

The company has $122.76 million in cash and $8.46 million in debt, giving a net cash position of $114.31 million or $1.57 per share.

Cash & Cash Equivalents	122.76M
Total Debt	8.46M
Net Cash	114.31M
Net Cash Per Share	$1.57
Equity (Book Value)	120.83M
Book Value Per Share	2.20
Working Capital	110.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$106.81 million and capital expenditures -$397,000, giving a free cash flow of -$107.21 million.

Operating Cash Flow	-106.81M
Capital Expenditures	-397,000
Free Cash Flow	-107.21M
FCF Per Share	-$1.47

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LXEO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.63%
Shareholder Yield	-54.63%
Earnings Yield	-15.38%
FCF Yield	-15.71%

Analyst Forecast

The average price target for LXEO is $18.22, which is 94.87% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.22
Price Target Difference	94.87%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1